Despite its acquisition by Roche AG, Genentech Inc. still has the best image amongst oncologists and hematologists, according to a study by Market Strategies International. BioWorld Insight explores what it takes to be beloved by cancer docs — including how both sales and research efforts factor into the equation — and what oncology companies need to do to compete with Genentech.

< Back to Library